Quantifying the Size of the Pterygium Head by Evaluating the Fibrous Area or the Vascularized Area.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 20 6 2020
medline: 1 7 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Pterygium is characterized by the development of wing-shaped fibrovascular tissue from the bulbar conjunctiva across the limbus onto the cornea. The purpose of this study was to quantify the discrepancy of the pterygium size between the fibrous area and the vascularized area. Color photographs of 146 eyes with pterygia obtained with a single-lens reflex camera system were analyzed by 2 independent graders for width (vertical dimension), length (horizontal dimension), and surface area of the pterygium head using 2 methods: the fibrous method, which measures any fibrovascular tissue crossing the corneal limbus, and the vascular method, which measures only tissue with discernible active blood flow, without any avascular tissue or opacity. Statistics of intraclass correlation coefficients for intergrader and intragrader reproducibility were calculated, and the paired t test between methods was used. Both intergrader and intragrader intraclass correlation coefficients for both methods were above 0.85. The vascular measurement was significantly larger in width (vertical dimension, fibrous 3.97 ± 1.02 mm vs. vascular 4.49 ± 1.33 mm, P = 0.01), whereas the fibrous measurement was significantly larger in length (horizontal dimension, fibrous 2.41 ± 1.16 mm vs. vascular 2.23 ± 1.05 mm, P = 0.04). No significant difference was found in the surface area (fibrous 7.27 ± 4.65 mm vs. vascular 7.40 ± 5.13 mm, P = 0.67). With both methods, reproducibility of the size of the pterygium head was high. Significant differences were shown between the two methods in quantification of the width and length but not in the surface area. Such methods can be used to standardize the evaluation of pterygia in clinical research and clinical trials.

Identifiants

pubmed: 32558733
doi: 10.1097/ICO.0000000000002355
pii: 00003226-202009000-00001
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1069-1072

Références

Carlock BH, Bienstock CA, Rogosnitzky M. Pterygium: nonsurgical treatment using topical dipyridamole: a case report. Case Rep Ophthalmol. 2014;5:98–103.
Hurmeric V, Vaddavalli P, Galor A, et al. Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium. Clin Ophthalmol. 2013;7:467–473.
Karalezli A, Kucukerdonmez C, Akova YA, et al. Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting? Int J Ophthalmol. 2014;7:512–516.
Kawano H, Kawano K, Sakamoto T. Separate limbal-conjunctival autograft transplantation using the inferior conjunctiva for primary pterygium. Oman J Ophthalmol. 2011;4:120–124.
Gumus K, Karakucuk S, Mirza GE, et al. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. Br J Ophthalmol. 2014;98:796–800.
Hirst LW. Cosmesis after pterygium extended removal followed by extended conjunctival transplant as assessed by a new, web-based grading system. Ophthalmology. 2011;118:1739–1746.
Kim KW, Park SH, Wee SW, et al. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency. Invest Ophthalmol Vis Sci. 2013;54:355–362.
Hilmi MR, Che Azemin MZ, Mohd Kamal K, et al. Prediction of changes in visual acuity and contrast sensitivity function by tissue redness after pterygium surgery. Curr Eye Res. 2017;42:852–856.
Huang P, Huang J, Tepelus T, et al. Validity of a new comprehensive pterygia grading scale for use in clinical research and clinical trial. Int Ophthalmol. 2018;38:2303–2311.
Livezeanu C, Crăiţoiu MM, Mănescu R, et al. Angiogenesis in the pathogenesis of pterygium. Rom J Morphol Embryol. 2011;52:837–844.
Aspiotis M, Tsanou E, Gorezis S, et al. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye (Lond). 2007;21:1095–1101.
Kim KW, Park SH, Wee SW, et al. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency. Invest Opthalmol Vis Sci. 2013;54:6355–6362.
Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235–1240.

Auteurs

Olivia L Lee (OL)

Donehy Image Reading Center, Doheny Eye Institute, Los Angeles, CA; and.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA.

Yue Shi (Y)

Donehy Image Reading Center, Doheny Eye Institute, Los Angeles, CA; and.

Tyler Brown (T)

Donehy Image Reading Center, Doheny Eye Institute, Los Angeles, CA; and.

Jyotsna Maram (J)

Donehy Image Reading Center, Doheny Eye Institute, Los Angeles, CA; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH